BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29795804)

  • 1. High-Throughput Screening Assay Datasets from the PubChem Database.
    Butkiewicz M; Wang Y; Bryant SH; Lowe EW; Weaver DC; Meiler J
    Chem Inform; 2017; 3(1):. PubMed ID: 29795804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
    Butkiewicz M; Lowe EW; Mueller R; Mendenhall JL; Teixeira PL; Weaver CD; Meiler J
    Molecules; 2013 Jan; 18(1):735-56. PubMed ID: 23299552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
    Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
    J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning.
    Buterez D; Janet JP; Kiddle SJ; Liò P
    J Chem Inf Model; 2023 May; 63(9):2667-2678. PubMed ID: 37058588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository.
    Helal KY; Maciejewski M; Gregori-Puigjané E; Glick M; Wassermann AM
    J Chem Inf Model; 2016 Feb; 56(2):390-8. PubMed ID: 26898267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learning.
    Soufan O; Ba-Alawi W; Afeef M; Essack M; Kalnis P; Bajic VB
    J Cheminform; 2016; 8():64. PubMed ID: 27895719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Screening Assay Profiling for Large Chemical Databases.
    Russo DP; Zhu H
    Methods Mol Biol; 2022; 2474():125-132. PubMed ID: 35294761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced HTS hit selection via a local hit rate analysis.
    Posner BA; Xi H; Mills JE
    J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS data.
    Lindh M; Svensson F; Schaal W; Zhang J; Sköld C; Brandt P; Karlén A
    J Chem Inf Model; 2015 Feb; 55(2):343-53. PubMed ID: 25564966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for mining highly imbalanced high-throughput screening data in PubChem.
    Li Q; Wang Y; Bryant SH
    Bioinformatics; 2009 Dec; 25(24):3310-6. PubMed ID: 19825798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
    Jenkins JL; Kao RY; Shapiro R
    Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results.
    Visser U; Abeyruwan S; Vempati U; Smith RP; Lemmon V; Schürer SC
    BMC Bioinformatics; 2011 Jun; 12():257. PubMed ID: 21702939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.
    Nakai R; Salisbury CM; Rosen H; Cravatt BF
    Bioorg Med Chem; 2009 Feb; 17(3):1101-8. PubMed ID: 18364257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and validating predictive decision tree models from mining chemical structural fingerprints and high-throughput screening data in PubChem.
    Han L; Wang Y; Bryant SH
    BMC Bioinformatics; 2008 Sep; 9():401. PubMed ID: 18817552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmarking Data Sets from PubChem BioAssay Data: Current Scenario and Room for Improvement.
    Tran-Nguyen VK; Rognan D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teaching an Old Dog New Tricks: Strategies That Improve Early Recognition in Similarity-Based Virtual Screening.
    Liu R; AbdulHameed MDM; Wallqvist A
    Front Chem; 2019; 7():701. PubMed ID: 31709231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.